On behalf of the European Alliance for Access to Safe Medicines, in its capacity as coordinator of the Nanomedicine Regulatory Coalition, you are kindly invited
It is no coincidence that Dr. Neelam Dhingra, Unit Head of WHO Patient Safety Flagship, recently stated that unsafe medication practices and medication errors are
The European Alliance for Access to Safe Medicines (EAASM) along with the members of the European Collaborative Action on Medication Errors and Traceability (ECAMET), organised
Brussels, 22 March 2022 Ahead of this year’s World Patient Safety Day focused on ‘Medication Safety’, the European Alliance for Access to Safe Medicines (EAASM)
Nanomedicines are medicinal products of at least one dimension in the nanoscale ranges – from 1nm to 100nm. They enhance the way in which medicines
The European Alliance for Access to Safe Medicines (EAASM) invites you to join its Parliament roundtable debate entitled “Preventing Medication errors across European hospitals to protect patient
Event summary of “Nanomedicines and nanosimilars: the medical need for a centralised EMA regulatory process” held as a live webinar on 30th November 2021 10.00-11.30
Nanomedicines enhance the way that medicines target and reach areas of disease within the body, opening up new therapeutic options. They offer potential solutions for
On behalf of the European Alliance for Access to Safe Medicines, you are kindly invited to join the upcoming virtual roundtable event on “Nanomedicines and
At the 4th plenary session of the Medicrime Committee of the Parties (CoP) the Alliance for Safe Online Pharmacy in the EU (ASOP EU) was voted in and